SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001127602-20-018281
Filing Date
2020-06-01
Accepted
2020-06-01 19:34:44
Documents
2
Period of Report
2020-05-27

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT form3.html 3  
1 PRIMARY DOCUMENT form3.xml 3 5656
2 POWER OF ATTORNEY (PUBLIC): SPURR POWER OF ATTORNEY doc1.txt EX-24 3458
  Complete submission text file 0001127602-20-018281.txt   10813
Mailing Address 2150 ST. ELZEAR BLVD. WEST LAVAL QUEBEC A8 H7L 4A8
Business Address 2150 ST. ELZEAR BLVD. WEST LAVAL QUEBEC A8 H7L 4A8 514-744-6792
Bausch Health Companies Inc. (Issuer) CIK: 0000885590 (see all company filings)

IRS No.: 000000000 | State of Incorp.: NJ | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O REPLIGEN CORPORATION 41 SEYON STREET WALTHAM MA 02453
Business Address
Spurr Robert (Reporting) CIK: 0001543795 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-14956 | Film No.: 20935278